Annual longevity blood test checklist by age 40, 50, and 60

Quick answer

An annual longevity blood test should start with decision-ready basics: lipids, glucose metabolism, complete blood count, kidney and liver markers, blood pressure context, and selected nutrient markers when risk factors justify them. Around age 40, establish a baseline. Around age 50, focus on trends and risk-based screening. Around age 60, re-baseline kidney function, anemia risk, thyroid context, medication effects, cardiovascular risk, and functional resilience.

Laboratory markers are most useful when they change action. Pair them with our heart-health priorities guide to connect lipids and glucose with blood pressure, nicotine exposure, movement, food, sleep, and treatment adherence.

Key facts

• Age 40 | is | a baseline decade for lipids, glucose, kidney, liver, CBC, blood pressure, waist, and family history.
• Age 50 | shifts | the checklist toward risk trends such as ApoB or non-HDL cholesterol, HbA1c, fasting glucose, blood pressure, waist, and inflammation.
• Age 60 | deserves | a function-focused re-baseline that includes kidney reserve, anemia patterns, thyroid context, medication effects, and cardiovascular risk.
• Longevity blood testing | works best | when each marker has a decision plan, not when the panel is simply larger.

Annual blood work is most useful when it answers a practical question. At 40, the question is usually “What is my baseline?” At 50, it becomes “Which risks are starting to show a pattern?” At 60, it shifts toward “What should I re-baseline before small changes become harder to reverse?”

This annual longevity blood test checklist is not a prescription and it does not replace a clinician’s judgment. It is a planning framework for discussing blood work with a doctor, comparing year-to-year trends, and avoiding two common mistakes: ordering a huge panel with no decision map, or repeating too little until a problem has been present for years. If your panel feeds a biological-age score, pair this checklist with how to explain a biological age result to your doctor so the appointment stays focused on raw markers and next steps.

If you need the broader panel logic first, start with our guide to blood tests for longevity and how often to repeat them. This article stays narrower: what to review yearly around ages 40, 50, and 60, and what can wait unless risk, symptoms, medication, or prior results justify it.

Key takeaways

• Age 40 is the best time to establish a stable baseline for lipids, glucose metabolism, kidney and liver markers, blood count, blood pressure context, and selected nutrient markers.
• Age 50 is when risk-based screening usually matters more than curiosity panels. Trends in ApoB or non-HDL cholesterol, HbA1c, fasting glucose, blood pressure, waist, and inflammation become more useful together than alone.
• Age 60 is a re-baseline decade. Kidney function, anemia patterns, medication effects, thyroid context, bone and vitamin status, and cardiovascular risk should be reviewed with more attention to function and resilience.
• The best cadence is usually annual for core labs, 3 to 6 months after a meaningful intervention or abnormal result, and longer intervals for stable markers that do not guide a decision.
• A single result rarely deserves a dramatic longevity conclusion. Repeat unexpected values under similar conditions before changing medication, supplements, or training.

The core annual panel

Most adults do not need an exotic longevity panel every year. A practical annual review usually begins with markers that clinicians already know how to interpret:

• Lipids: ApoB if available, LDL-C, HDL-C, triglycerides, non-HDL cholesterol, and total cholesterol.
• Glucose metabolism: fasting glucose and HbA1c, with fasting insulin or HOMA-IR when the decision question is insulin resistance rather than diabetes screening alone.
• Complete blood count: hemoglobin, hematocrit, white blood cells, platelets, RDW, and differential context.
• Comprehensive metabolic panel: creatinine, eGFR, electrolytes, albumin, ALT, AST, alkaline phosphatase, bilirubin, and related liver or kidney context.
• Inflammation: hs-CRP when the result will be interpreted cautiously and repeated if unexpectedly high.
• Thyroid: TSH as a first screen, with free T4 and additional markers when symptoms, medication, or prior results justify them.
• Nutrients when relevant: vitamin D, B12, ferritin, iron studies, magnesium, or folate based on diet, symptoms, medication, history, or prior abnormal values.

This list is deliberately plain. Longevity tracking works better when the basics are repeated cleanly and connected to weight, waist, blood pressure, fitness, sleep, medications, symptoms, and family history. For marker-by-marker interpretation, use our blood work guide for longevity.

What to baseline around age 40

At 40, blood work should create a clean starting line. Many people still feel healthy, but risk patterns often become visible if you know where to look. The most useful baseline includes lipids, glucose metabolism, kidney and liver markers, blood count, blood pressure history, waist or body-composition context, and family history.

This is also the decade to stop treating “normal” as the only question. A normal LDL-C with a high ApoB, a normal fasting glucose with rising HbA1c, or a normal weight with increasing waist can all deserve a more careful trend review. If you track wearables, combine yearly labs with resting heart rate, HRV, cardio fitness, sleep regularity, and activity trends rather than reading either dataset in isolation.

Ask your clinician which risk-based screens apply. The USPSTF recommends screening adults 35 to 70 with overweight or obesity for prediabetes and type 2 diabetes. It also recommends blood pressure screening in adults and risk-based statin decisions for many adults 40 to 75 with cardiovascular risk factors. Those recommendations are not “longevity hacks.” They are the mainstream baseline that many advanced panels should not distract from.

What to emphasize around age 50

At 50, the annual checklist becomes more risk-specific. Lipids, glucose, kidney markers, liver enzymes, blood count, and blood pressure remain central, but the question changes from “What is my baseline?” to “Which trend needs action before it becomes disease?”

This is a good decade to review ApoB or non-HDL cholesterol if you have not already, because particle-related lipid risk can be missed when LDL-C looks reassuring. It is also a good time to compare HbA1c, fasting glucose, triglycerides, waist, sleep, and activity together. If triglycerides are high but ApoB is normal, use our guide to high triglycerides with normal ApoB before assuming the pattern means one thing.

Inflammation markers can help, but only when interpreted calmly. A single high hs-CRP after illness, hard training, dental work, poor sleep, or injury may not represent your usual baseline. If hs-CRP is unexpectedly high, read our guide on when to repeat hs-CRP after one high result and discuss a repeat plan.

Age 50 is also when immunization and preventive-care calendars become more relevant. CDC adult schedules include age-based recommendations such as shingles vaccination beginning at 50 and pneumococcal guidance that changes with age and risk. Blood tests do not replace those basics.

What to re-baseline around age 60

At 60, the goal is not simply to add more markers. The goal is to re-baseline the systems that affect function: cardiovascular risk, glucose control, kidney reserve, liver function, anemia risk, thyroid context, nutrient sufficiency, inflammation, and medication effects.

Kidney markers deserve more attention because eGFR can decline with age and medication choices often depend on kidney function. CBC patterns matter because anemia, high RDW, low white cells, or platelet changes can affect energy and resilience. Liver enzymes and albumin can provide context for medication, alcohol, metabolic health, and nutrition. Thyroid markers are worth reviewing when symptoms, medications, atrial rhythm issues, bone health, or prior TSH changes make them relevant.

This is also a useful decade to compare lab data with functional metrics. Strength, gait speed, balance, VO2 max, activity tolerance, sleep, and recovery patterns often reveal problems earlier than a single lab marker. SuperAge is strongest when you use it to connect those trends rather than turning one result into a verdict.

Cadence: yearly, 3 months, or 6 months?

A yearly check is reasonable for many stable core markers. A 3-month repeat is more useful after a medication change, nutrition intervention, meaningful weight change, high-risk result, or abnormal value that needs confirmation. A 6-month repeat often fits borderline patterns where action is underway but the marker is not urgent.

Avoid retesting everything monthly unless a clinician is actively managing a condition. Biological variation, sleep disruption, travel, illness, training load, menstrual cycle timing, alcohol, and collection differences can all move results. The more often you test, the more disciplined you need to be about interpreting noise.

How SuperAge fits

SuperAge helps after the blood draw. Store your lab values, review them beside Apple Health and wearable trends, and watch whether changes are consistent across systems. A lower resting heart rate, better sleep regularity, improved fitness, stable ApoB, lower triglycerides, better HbA1c, and a repeatable hs-CRP baseline tell a more useful story together than any single score.

For home testing decisions, compare this checklist with our guide to the best home biomarker tests for longevity. The right panel is the one you can repeat, interpret, and act on without confusing more data with better decisions.

Ready to make your annual labs easier to interpret? Download SuperAge and track your blood markers alongside sleep, fitness, recovery, and biological age.

Frequently asked questions

Do I need a large longevity blood panel every year?

No. Most people get more value from a repeatable core panel with a clear decision plan than from a very large annual panel. Add specialized markers when symptoms, risk, medication, family history, or prior results make them useful.

Should ApoB be checked every year?

It depends on your cardiovascular risk and treatment plan. ApoB can be useful when LDL-C, triglycerides, metabolic risk, or family history do not tell the whole story, but the repeat interval should be tied to a decision rather than curiosity alone.

How soon should I repeat abnormal blood work?

Ask your clinician. Many borderline or unexpected results are repeated after similar conditions, often within 3 to 6 months when an intervention is underway, and sooner when the result is high-risk or could change treatment.

Are home biomarker tests enough for annual longevity tracking?

Home tests can help with convenience and trend tracking, but they should not replace clinical interpretation, physical exam context, blood pressure measurement, medication review, or age-appropriate preventive care.

For a narrower decision guide, see Health markers to re-baseline at 60.

For a narrower decision guide, see Midlife health audit: what to measure before symptoms appear.

References

Use this checklist as a doctor-discussion tool. For screening context, see the USPSTF recommendations on prediabetes and type 2 diabetes screening, hypertension screening, and statin use for primary prevention. For immunization timing, review the CDC adult immunization schedule.